Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 98

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

HLA‐B*35:01 and Green Tea–Induced Liver Injury

Hoofnagle, Jay H., Bonkovsky, Herbert L., Phillips, Elizabeth J., Li, Yi‐Ju, Ahmad, Jawad, Barnhart, Huiman, Durazo, Francisco, Fontana, Robert J., Gu, Jiezhun, Khan, Ikhlas, Kleiner, David E., Koh, Christopher, Rockey, Don C., Seeff, Leonard B., Serrano, Jose, Stolz, Andrew, Tillmann, Hans L., Vuppalanchi, Raj, Navarro, Victor J., for the Drug‐Induced Liver Injury Network·2021·Hepatology
DOI 10.1002/hep.31538PMC PMC8052949
Open this paper in CoChat — free account

Abstract

Background and Aims: Herbal supplements, and particularly multi‐ingredient products, have become increasingly common causes of acute liver injury. Green tea is a frequent component in implicated products, but its role in liver injury is controversial. The aim of this study was to better characterize the clinical features, outcomes, and pathogenesis of green tea‐associated liver injury. Approach and Results: Among 1,414 patients enrolled in the U.S. Drug‐Induced Liver Injury Network who underwent formal causality assessment, 40 cases (3%) were attributed to green tea, 202 to dietary supplements without green tea, and 1,142 to conventional drugs. The clinical features of green tea cases and representation of human leukocyte antigen (HLA) class I and II alleles in cases and control were analyzed in detail. Patients with green tea–associated liver injury ranged in age from 17 to 69 years (median = 40) and developed symptoms 15‐448 days (median = 72) after starting the implicated agent. The liver injury was typically hepatocellular (95%) with marked serum aminotransferase elevations and only modest increases in alkaline phosphatase. Most patients were jaundiced (83%) and symptomatic (88%). The course was judged as severe in 14 patients (35%), necessitating liver transplantation in 3 (8%), but rarely resulting in chronic injury (3%). In three instances, injury recurred upon re‐exposure to green tea with similar clinical features, but shorter time to onset. HLA typing revealed a high prevalence of HLA‐B*35:01, found in 72% (95% confidence interval [CI], 58‐87) of green tea cases, but only 15% (95% CI, 10‐20) caused by other supplements and 12% (95% CI, 10‐14) attributed to drugs, the latter rate being similar to population controls (11%; 95% CI, 10.5‐11.5). Conclusions: Green tea–related liver injury has distinctive clinical features and close association with HLA‐B*35:01, suggesting that it is idiosyncratic and immune mediated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.31538

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 2

  1. 2010, Black cohosh products and liver toxicity: update, Can Adverse Reaction Newsletter, 20, 1
  2. 2015, Drug‐induced liver injury in the United States: a report of 899 events prospectively assessed, Gastroenterology, 148, 1340

Cited by

See all 98

Metadata

Authors
Hoofnagle, J. H., Bonkovsky, H. L., Phillips, E. J., Li, Y., Ahmad, J., Barnhart, H., Durazo, F., Fontana, R. J., Gu, J., Khan, I., Kleiner, D. E., Koh, C., Rockey, D. C., Seeff, L. B., Serrano, J., Stolz, A., Tillmann, H. L., Vuppalanchi, R., Navarro, V. J., & for the Drug‐Induced Liver Injury Network
Affiliations
  • Liver Disease Research Branch,Division of Digestive Diseases and Nutrition,National Institute of Diabetes and Digestive and Kidney Diseases,National Institutes of Health (NIH),Bethesda,MD
  • National Cancer Institute,National Institutes of Health (NIH),Bethesda,MD
  • Department of Medicine,Vanderbilt University Medical Center,Nashville,TN
  • Duke Clinical Research Institute,Duke University,Durham,NC
  • Department of Medicine,Icahn School of Medicine at Mount Sinai,New York,NY
  • University of California Los Angeles,David Geffen School of Medicine,Los Angeles,CA
  • Department of Medicine,University of Michigan School of Medicine,Ann Arbor,MI
  • National Center for Natural Products Research,University of Mississippi,University,MI
  • The Laboratory of Pathology,National Cancer Institute, NIH,Bethesda,MD
  • Liver Diseases Branch,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),Bethesda,MD
  • Digestive Disease Research Center,Medical University of South Carolina,Charleston,SC
  • Department of Medicine,Einstein Healthcare Network,Philadelphia,PA
  • Department of Medicine,University of Southern California School of Medicine,Los Angeles,CA
  • Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine,East Carolina University,Greenville,NC
  • Department of Medicine,Indiana University School of Medicine,Indianapolis,IN
ORCID
Vuppalanchi, Raj
Venue
Hepatology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2021-05-17
Volume
73
Issue
6
Pages
2484-2493
ISSN
  • 0270-9139
  • 1527-3350
DOI
10.1002/hep.31538
PMC
PMC8052949
Cited by
98
References
36
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.